BRIDGEBIO PHARMA INC - NOTE 2.500% 3/1

Historical Portfolio Holders from Q1 2021 to Q3 2024

All holders as of June 30, 2024
Q2 2024
Type / Class
Debt / NOTE 2.500% 3/1
Principal, excl. options Q2 2024
560M
Holdings value Q2 2024
$566M
Value change Q2 2024
+$19.4M
Grand Portfolio weight change Q2 2024
+0%
Number of holders
40
Number of buys Q2 2024
20
Number of sells Q2 2024
-15
Average buys Q2 2024 %
+0%
Average sells Q2 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Principal Value Change Price Investors
2024 Q3 $329K $339K $0 $1.03 2
2024 Q2 $560M $566M +$19.4M $1.01 40
2024 Q1 $541M $582M +$10.1M $1.08 39
2023 Q4 $530M $642M +$9.64M $1.21 44
2023 Q3 $528M $511M +$30M $0.96 40
2023 Q2 $509M $401M -$17.1M $0.78 33
2023 Q1 $24.4M $29.8M -$9.28M $73.29 5
2022 Q4 $532M $236M -$943K $0.45 30
2022 Q3 $392M $242M +$158K $0.59 30
2022 Q2 $403M $229M -$80.9M $0.55 30
2022 Q1 $546M $332M -$4.27M $0.59 32
2021 Q4 $522M $380M -$37.3M $0.73 37
2021 Q3 $532M $739M -$47.1M $1.38 39
2021 Q2 $570M $936M +$76.5M $1.64 38
2021 Q1 $519M $859M +$842M $1.65 34